R&D software company ArtusLabs has been acquired by life science and health IT company PerkinElmer (NYSE:PKI) as one of a pair of deals intended to boost the Massachusetts company’s offerings for the pharmaceutical industry. Durham, North Carolina-based ArtusLabs’ software offers scientific data mining among other capabilities and is used by pharmaceutical industry researchers and others […]
PerkinElmer expects the sale of its illumination and detection solutions unit to increase adjusted gross margins by 200 basis points. "The completion of the transaction also frees up capital to reinvest in our more attractive businesses, and pursue targeted acquisitions to complement and expand our portfolio, as well as repurchase shares," CEO Robert Friel said in a statement announcing the deal's closure.
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.